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Summary
Gynoid lipodystrophy (GLD) is a structural, inflammatory, and biochemical disorder of
the subcutaneous tissue causing alterations in the topography of the skin. Commonly
known as “cellulite,” GLD affects up to 90% of women, practically in all stages of the
life cycle, beginning in puberty. It is a clinical condition that considerably affects the
patients’ quality of life. It is a frequent reason for consultation, although the patients
resort to empirical, improvised, nonevidence-based treatments which discourage and
can be a source of frustration not only because of the lack of results but also due to
the complications derived from those treatments. In this article, a panel of experts
from different specialties involved in the management of this clinical skin disorder
presents the results of a systematic literature search and of the consensus discussion
of the evidence obtained from different treatments currently available. The analysis
was divided into topical, systemic, noninvasive, and minimally invasive treatments.
Resumen
La lipodistrofia ginoide (LDG) es una alteracion estructural, inflamatoria y bioquımica
del tejido subcutaneo que causa modificaciones topograficas en la piel. Conocida
comunmente como “celulitis”, la LDG afecta hasta a 90% de las mujeres, practica-
mente en todas las etapas de la vida, iniciando en la pubertad. Se trata de una con-
dicion que afecta considerablemente la calidad de vida de quien la padece. Es
motivo frecuente de consulta aunque las pacientes recurren a tratamientos empıri-
cos, improvisados, sin bases ni evidencia cientıfica, los cuales desmotivan y produ-
cen frustracion no solo por su falta de resultados, sino por complicaciones derivadas
de dichos tratamientos. Un grupo de expertos de diversas especialidades involucra-
das en el manejo de este problema presenta en este artıculo el resultado de una
busqueda bibliografica sistematica y de la discusion consensuada de la evidencia
obtenida de diversos tratamientos disponibles actualmente. El analisis se dividio en
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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tratamientos topicos, tratamientos sistemicos, tratamientos no invasivos y tratamien-
tos mınimamente invasivos.
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1 | INTRODUCTION
Gynoid lipodystrophy (GLD) is a structural, inflammatory, and bio-
chemical disorder of the subcutaneous tissue that causes alterations
in skin topography. Such changes derive in skin protrusions and
depressions, mainly localized in the buttocks, lower limbs, pelvic
region, and abdomen.1
Commonly known as “cellulite,” GLD occurs predominantly in up
to 90% of adult women. It may begin after puberty, but it is more
evident in women over 30 years old, overweight, and thin patients;
men rarely have it.2,3
Even though it is not a life-threatening clinical condition, GLD
affects most women’s psychosocial sphere because it is directly and
inexorably related to the physical appearance, self-esteem, and, conse-
quently to the well-being perception and social acceptance. Thus, the
main reason to look for a treatment for GLD is its esthetic appearance.4
2 | ETIOPATHOGENESIS
Gynoid lipodystrophy is a complex and multifactorial condition that
includes triggering, perpetuating, and exacerbating factors. It may be
the result of structural, biochemical, metabolic, inflammatory, and
morphological alterations, but a unique etiopathogenic explanation is
not yet determined.5 The main hypothesis are detailed below.
2.1 | Genetics
One of the main hypotheses of GLD etiopathogenesis is genetics.
Friedman et al found that ACE rs1799752 and HIF1A rs11549465
polymorphisms in the subcutaneous tissue are related to GLD. The for-
mer increases the activity of the angiotensin converting enzyme (ACE)
and the disturbances in tissue oxygenation, whereas the latter protects
against the microhypoxic and fibroinflammatory tissue responses.2
Another revision study conducted by Emanuele et al found that
women carrying the D allele of ACE increases the risk of developing
GLD because it is related to the production of angiotensin II in the
fat subcutaneous tissue. This fosters the disturbance of the blood-
stream and enables the adipocyte oxygenation (high deposition of
extracellular matrix and the formation of complex networks of sub-
cutaneous fibrous tissue).6,7
In a controlled study, Emanuele et al found that the adiponectin
mRNA expression is low in the subcutaneous fat tissue of areas
affected by GLD, whereas there are no adiponectin changes in plasma.6
Even, some controlled clinical studies have found a significant
correlation between tobacco use and a genetic component which
may favor the development of GLD. ACE converts angiotensin I into
angiotensin II and degrades bradykinin, which contributes to the
decrease in the local bloodstream. ACE activity is genetically deter-
mined by an insertion/deletion polymorphism in thin women.
Tobacco smoking induces oxidative stress and may promote the
release of a proteolytic enzyme which alters the production of the
connective tissue of the skin. In other words, there is a synergy
between such genetic polymorphism and tobacco use.8
2.2 | Hormones
The estrogenic hormone processes play an important role on GLD
etiopathogenesis. Evidence shows that such processes elicit lipogen-
esis and inhibit lipolysis which results in hypertrophy of the fat tis-
sue. This mechanism may partially explain a higher prevalence of
GDL in women and a casual correlation due to an exacerbation of
this condition during high-estrogen periods, that is to say, during
pregnancy, breastfeeding, menstruation, and oral contraceptives
use.9 In other words, estrogens expose the sites where GLD is more
common because such places have more hormone activity.
2.3 | Vascular and low-grade chronic inflammation
An extensively studied theory about GLD etiopathogenesis is the
disturbance of the microvascular and lymphatic circulation of the
subcutaneous fat tissue. In buttocks and thighs (sites where the lym-
phatic drainage and the vascular circulation are low), there is a
higher predisposition to microedema increase in the subcutaneous
fat layers, which fosters abnormalities in the skin.10
Rossi proposed four evolutionary stages in the GLD pathophysi-
ology9:
• Modifications in the capillo-venular-lymphatic permeability, as well
as capillary ectasia and intercapillary and interadipose edema.
• Edema that causes metabolic changes and results in hyperplasia
and hypertrophy of the reticular structure.
• Collagen fibers joining around the adipocytes and form adipose
micronodules.
• Sclerosis development that induces the formation of adipose
macronodules.
Based on some cases reporting dermal and subdermal sensibility
when pressing areas with GLD, inflammatory processes are
978 | PEREZ ATAMOROS ET AL.
suspected. According to the evidence, macrophage and lymphocyte
have been reported in the fibrous septa of biopsies of tissue with
GLD, which shows the potential development of low-grade chronic
inflammation and dermal atrophy.11
2.4 | Morphology
Magnetic resonance imaging has confirmed that topographic modifi-
cations and clinic appearance of GLD are related to a significant
increase in the presence and thickness of the subcutaneous fibrous
septa.12 The cutaneous depressions observed in GLD are the result of
tension the fibrous septa execute downwards in a perpendicular
direction to the surface of the skin, while the protruded areas are the
projection of adipose chambers delimitated by fibrous septa.1
Another study reported that women with GLD have a higher percent-
age of fibrous septa, compared with men or women without GLD.13
3 | EVALUATION AND CLASSIFICATION
Evaluation and grading of GLD are crucial to determine the best
treatment and to follow up the results. Nevertheless, it is important
to take into account that some methods to assess GLD may be
regarded slightly objective as the anthropometric measures (weight
and body circumference) because they indirectly measure the adi-
pose panicle.14
In any case, one of the main tests is performing a clinical exami-
nation while the patient is in a standing position and tightens the
skin because that increases defects and it is useful during evaluation.
The pinching test may be performed to make the lesions visible.1 It
is recommended to take and record digital photographs before and
after the treatment. Taking the pictures should follow the same stan-
dards, including the light patterns, position, and adjustment of the
camera.1
De la Casa et al suggest that the pictures of co-occurrence
matrices (glcm, gray-level co-occurrence matrices) should measure
energy (textural uniformity), entropy (disorder, complex images,
inversely related to uniformity), contrast (gray-scale variations in the
image pixels), homogeneity (consistency of the local image), and their
correlation with the texture of the site to be evaluated in relaxation
and in contraction. This technique differentiates benign melanocytic
nevus in normal skin.14
Another method to confirm GLD diagnosis is 2D magnetic reso-
nance image because it shows the lipid composition of the normal
and adipose tissues.13 It also shows the specific changes in the sub-
cutaneous architecture caused by cellulite.15
Ultrasound is also useful to examine thickness, quality of the
connective tissue, and to observe the edematous component of cel-
lulite.1 Image by ultrasound reveals dermal thinning and subcuta-
neous fat pushing it upwards. At 20 MHz frequency, ultrasound
shows that adipose protrusions in the dermis are related to cellulite
severity. This technique allows seeing the fat layers, but it is not rou-
tinely recommended.
Doppler laser flowmeter is also useful to establish a GLD diagno-
sis because it assess cutaneous microcirculation of the skin to obtain
data of the blood flow and eritema.1
Likewise, cellulite may be confirmed by thermography and infra-
red thermal camera because GLD areas are characterized by low
blood flow and low temperatures.1
Hexsel’s and Dal0forno’s alphanumeric classification Cellulite
Severity Scale (CSS) has become a selection tool to graduate GLD
severity because it is based on five clinical and morphological
aspects: (1) number of evident depressions, (2) depth of depressions,
(3) morphological appearance of the skin surface, (4) grade of flaccid-
ity, and (5) GLD grade. Each of them is ranked from 0 to 3. The sum
of all the items shows GLD severity: mild, moderate, or severe16
(Table 1).
In any case, the more simplicity and reproducibility the scale has,
it is preferred.
Kaminer et al have described a CSS simplified classification
(Table 2) which was developed and validated for a clinical study. It
includes two clinical-morphological items: (a) number of evident
depressions and (b) depth of depressions. The severity of each item
is classified from 0 to 3 based on the definition and on the set of
photographs taken at baseline. The total score is calculated from the
sum of A and B values and the later subtraction of 1. The result
shows a qualitative measure converted into a severity scale from 0
to 3, which is equivalent to none, mild, moderate, and severe
(Table 2).17
TABLE 1 Severity scale of GLD (Hexsel’s and Dal0forno’s, Cellulite
Severity Scale, CSS)
Number of evident depressions
0 = No depression
1 = Small quantity (1-4 depressions)
2 = Moderate quantity (5-9 depressions)
3 = Large quantity (10 or more depressions)
Depth of depressions
0 = No depressions
1 = Superficial
2 = Median depth
3 = Depth
Morphological appearance of the skin alterations
0 = No protrusions
1 = Orange peel
2 = Cottage cheese
3 = Mattress phenomenon
Grade of laxity, flaccidity, or sagging skin
0 = The absence of laxity, flaccidity, or sagging skin
1 = Mild draped appearance
2 = Moderate draped appearance
3 = Severe draped appearance
Adapted from Hexsel and Dal0forno.16
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4 | TREATMENT
It is a common recommendation to change lifestyle to reduce GLD;
that is to say, to modify diet and do exercise regularly with the pur-
pose of controlling body weight and, consequently, to reduce
cellulite.
The food industry has conducted research to analyze how conju-
gated linoleic acid decreases GLD signs because it is a powerful
PPAR-alpha activator that improves the epidermal differentiation,
reduces inflammation (which increases the extracellular matrix com-
ponents), and favors bright in the skin. Nevertheless, there is scarce
evidence showing the unquestionable and long-term efficacy of
these measures in the GLD treatment.18
The available therapeutic options for GLD are numerous and
range from conventional modalities (topical applications and mas-
sages, intense pulsed light, acoustic waves, and radiofrequency) to
minimally invasive approaches such as subcision, laser therapy, and
injections. Their objectives are improving the esthetic appearance of
the skin and maintaining treatment response as long as possible.
Clinical evidence for most of the modalities provides positive
results in efficacy; however, it is still scarce and slightly consistent;
thus, more research is needed to confirm such results. In any case,
we can classify GLD treatments into topical, pharmacological, nonin-
vasive, and minimally invasive.
4.1 | Topical
Numerous are the ingredients used in topical presentations to treat
GLD. Most of the products contain caffeine, retinol, or botanical
derivatives as active ingredients. The potential effects are lipolysis,
lymphatic drainage, stimulation of peripheral microcirculation, edema
reduction, and stimulation of collagen production.9 Methylxanthines
such as caffeine, aminophylline, or theophylline are the main cate-
gory whose action has been documented to treat GLD. Their use is
based on the potential to induce lipolysis in adipose tissue by inhibit-
ing the activity of phosphodiesterase enzyme. Caffeine also has a
stimulant effect on cutaneous microcirculation and as an antioxi-
dant.19
Retinoic acid and vitamin A derivatives are widely used in GLD
because they increase the collagen thickness, improve the elastic
fibers, and function as inhibitors of the differentiation of human
adipocyte precursor cells.9
Extracts of Ginkgo biloba leaves are also used to improve the
appearance of GLD because they contain flavonoids, bioflavonoids,
and terpenes. These substances improve the local microcirculation
when reducing the blood viscosity, inhibit the platelet growth factor,
diminish the capillary permeability, and improve the tone of the ves-
sel wall.9 Other botanical derivatives such as Centella asiatica, Ruscus
aculeatus, Carica papaya, Vitis vinıfera, Glycyrrhiza glabra, and Aesculus
hippocastanum have been used because of their potential as promot-
ers of microcirculation and because they improve the lymphatic
drainage.9,20,21
As a rule, topical treatments are intended to improve the appear-
ance and skin texture (orange peel, cottage peel), but they only have
a transient effect, that is to say, they do not improve the retraction
caused by fibrous septa.
4.2 | Massage
Mechanical stimulation by massages is one of the oldest methods to
treat GLD. It is thought it promotes lymphatic drainage and the
microcirculation of the subcutaneous tissue, which diminishes lym-
phedema associated with GLD. It may be manual or performed with
the assistance of devices; one of them execute positive and negative
pressure to the skin and to the subcutaneous tissue, which is
believed to cause a nonlethal damage to the adipocytes which are
distributed and achieve a better skin contour.22,23
4.3 | Pharmacological (oral)
In a systematic revision (67 clinical studies) of the current
management for GLD, it was found that in spite of the contradictory
views about the effectiveness of oral treatments for GLD, the
commonest are considered nutritional supplements made from
extracts of Vitis vinıfera (grape), Ginkgo biloba, Centella asiatica,
Mellilotus officinalis, Fucus vesiculosus, fish oil, and borage oil. Their
antioxidant effects inhibit the oxidation of the tissue molecules.
Another option included in this revision is drinking aronia juice
because it enhances the cellular metabolism, increases collagen and
elastin synthesis; reduces edema and bowel inflammation; and
improves microcirculation.24
Another group of researchers proposes the use of Dioscorea oppo-
sita, Theobroma cacao, Aesculus hippocastanum, A. hippocastanum, and
TABLE 2 GLD severity according to independent testers
Score Description
A. Number of evident depressions
0 None
1 Mild (≤4 depressions)
2 Moderate (≥5 to ≤9 depressions)
3 Severe (≥10 depressions)
B. Average depth of the depressions
0 None
1 Mild (1-2 mm)
2 Moderate (3-4 mm)
3 Severe (≥5 mm)
Severity grade
Severity scale (A + B—according
to testers’ scores) Classification Severity
0 None 0
1-2 Mild 1
3 Moderate 2
4-5 Severe 3
Adapted from Kaminer et al17
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Solanum ycopersicum because their extract regulates the release of
glycerol from the adipocytes that decrease the fat content in the tis-
sue.25,26
4.4 | Noninvasive
Noninvasive devices based on energy.
4.4.1 | Acoustic waves
The transmission of acoustic waves toward subcutaneous tissue
seems to be a safe alternative in the GLD treatment.27,28 Evidence
shows that shock waves of this technique—widely used in urology
to fragment kidney stones—in GLD promote lipolysis when breaking
the cellular wall of the adipocyte, improve local blood flow, and
enable lymphatic drainage with the subsequent lymphedema
decrease. Likewise, it seems to stimulate collagen and elastin produc-
tion, which improves skin elasticity.24
Nevertheless, a systematic revision does not show positive results
related to the efficacy of the acoustic waves devices24; thus, more
clinical studies are needed to increase the consistency of the results.
4.4.2 | Radiofrequency
Radiofrequency devices (RF) heat the target area due to the resis-
tance to the flow of electric current in the dermis and subcutaneous
tissue. Such phenomenon is known as bioelectrical impedance, and
its objective is decreasing the appearance of cellulite when affecting
the connective septal and adipose tissue.5
There are mainly two types of devices emitting energy by
radiofrequency: unipolar and bipolar. The most important difference
between them is the depth the thermic wave reaches. The former
reach deeper layers and comprise most part of the subcutaneous tis-
sue, whereas the latter usually reach the depth of the deep dermis
and the most superficial part of the subcutaneous cellular tissue.
Such mechanism is used in GLD due to its capacity to induce
collagen production, tissue restructuring, and adipocyte lysis.5 It is
believed that heat released to the subcutaneous layer is absorbed by
adipocytes in order to induce cell breakage by membrane lysis. Sub-
sequently, a process of repair by production of collagen would
improve the tissue characteristics, making it firmer and improving
the clinical appearance of GLD.2
RF is usually used in combination with other techniques such as
ultrasound, infrared light, suction, but according to a systematic revi-
sion of evidence, RF effectiveness alone or in combination is limited.
The results of clinical studies do not show systematic analysis or
complete and definite resolution of GLD; thus, more randomized
studies with larger samples are needed to confirm results.24
4.4.3 | Infrared light and intense pulsated light
Heat generated by infrared light on the skin implies an increase in
microcirculation, lymphatic drainage, and collagen synthesis. The
process of collagen denaturalization induces its contraction, thicken-
ing, and later skin tightening. It may also be combined with laser
techniques and mechanical stimulation.5
Intense pulsated light (IPL) is based on the supposition that this
technique promotes collagen generation and induces firmer dermis.
Dermal damage executed by this energy promotes subsequent repair
and remodeling of collagen. Hence, it is believed that IPL improves
the esthetic appearance of GLD.22
Due to the depth of these treatments (exclusively cutaneous),
results are not significant or lasting, specifically for GLD.
4.4.4 | Ultrasound
Focused ultrasound is now used in GLD because of its effects in the
structural alteration of tissues; mainly by dermal damage and microme-
chanical disruption.29 The energy released by open ultrasonic waves
promotes disruption of the adipocyte cellular wall. It is thought that
this system (known as cavitation) reduces fat tissue volume. However,
the damage it may provoke to the deep tissues has not been con-
firmed. Several systems using ultrasonic waves have been developed
to treat GLD in combination with other techniques and procedures like
radiofrequency and the results of their efficacy seem to have a basis.30
4.4.5 | Criolypolisis
Technology of controlled freezing of subcutaneous cellular tissue
was approved by FDA to be applied in order to reduce fat volume;
its use in GLD treatment is still under research.31,32
4.5 | Minimally invasive
4.5.1 | Carboxytherapy33
Carboxytherapy is a technique or nonsurgical procedure whereby
carbon dioxide (CO2) is administered intradermally by means of a
machine that regulates gas flow. This procedure is used to fight
excess fat from the body, cellulite, body and facial aging, flaccidity,
varicose micro-veins, and to reduce scars and stretch marks. It is also
used as a postoperative treatment of liposuction or esthetic surgery
to correct skin irregularities, to prevent fibrosis, and to improve
results. CO2 administration in subcutaneous tissue induces hypercap-
nia and reduces local pH, which derives in a considerable vasodilat-
ing response by the relaxation of the prearteriolar smooth muscle at
the site of application.33
According to the expertise of the authors of this document, car-
boxytherapy acts in GLD at four levels:
• Improves blood and lymphatic flows, which facilitates drainage of
the retained liquid.
• Improves the tone of the skin, which restores elasticity and coun-
ters the typical sagging in GLD.
• Reduces fatty deposits and, consequently, the orange appearance
of the skin.
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• Fight fibrosis because it improves blood microcirculation and
restores skin elasticity (decrease of the characteristic dimples of
the skin with GLD).
In their study, Ramalho et al found that carboxytherapy is effec-
tive to treat abdomen, thighs, and/or knees (localized adiposities)
which showed circumference reduction after treatment. In that same
article, it is also emphasized that the lipolytic effect of carboxyther-
apy increases the collagen remodeling induced by intradermal CO2
injections. It is also described that this technique promotes vasodila-
tion of the microcirculation, increase in peripheral blood and temper-
ature at the injection site.33
Notwithstanding Ramalho’s sample is small, the results Lee
obtained in a sample including 101 patients also confirms the effec-
tiveness of this technique. In the case of GLD, specifically, there was
reduction in GLD grades III and II.34 Obviously, more controlled
studies and with larger samples are required to confirm that car-
boxytherapy is an evidence-based treatment.
4.5.2 | Mesotherapy and enzymes
Mesotherapy is the subcutaneous injection of several compounds
such as collagenases, caffeine, hyaluronidase, carnitine, amino-
phylline, phosphatidylcholine, lipase, amylase, catalase, cathepsin,
among others. Hyaluronidase, for instance, acts as an enzyme in
epithelial and connective tissues promoting depolymerization of
fibrous edema in interstitial tissue and enabling local metabolic
changes.35
Phosphatidylcholine injections—particularly sodium deoxycholate
of the formulation—model the body; it is focused on the fatty
deposits in the subcutaneous tissue and induces lipolysis by the acti-
vation of cyclic monophosphate.36,37
This approach is chosen because lipases catalyze numerous reac-
tions, including hydrolysis, inter-esterification, aminolysis, lipolysis,
among others.29 Even though this technique has been used in differ-
ent conditions, its efficacy in GLD has not been consistently demon-
strated due to the substance variability and different mechanisms of
action.22,24,38
Another up-to-date option to treat GLD is neocollagenesis by der-
mal filling with biodegradable injections of calcium hydroxyapatite
microspheres. This minimally invasive procedure is safe, well-tolerated,
and obtains good results because calcium hydroxyapatite micro-
spheres stimulate collagen and elastin formation, besides improving
microcirculation at a local level, which generates a long-term quality of
life of skin and a better appearance of GLD. This treatment may be
applied alone or in combination with other therapies.
4.5.3 | Subcision
Subcision is an effective surgical technique used to divide bands or
subcutaneous fibrous septa and release the underlying skin, which
results in a smoother and softer cutaneous topography.
The principle sustaining its use in the treatment of cellulite is the
evidence showing that fibrous septa fix and depress the skin verti-
cally toward the subcutaneous tissue, which causes evident depres-
sions on the cutaneous surface. The most common methods have
been liposuction cannulas, laser thermal guide (Nd:Yag 1440 nm),
needles, all of them manually operated. The objective is releasing the
skin to obtain a uniform surface.2
The latest treatment is a subcision system (TS-GS, Tissue Stabi-
lized Guided Subcision) developed to gain more control, precision,
reproducibility, and safety. It is a device approved by FDA and CE-
Marked; it treats the structural underlying cause of cellulite by an
accurate release of the fibrous septa by a suction system and
microblades.39
The clinical improvement achieved after using this technique
results from the release of the fibrous septa, performed at an exact
depth of 6 to 10 mm, which allows the re-distribution of the subcu-
taneous tensional forces that minimize the protrusion of the fat tis-
sue. Evidence of multicenter clinical studies show that TS-GS is
effective and safe to improve GLD appearance and that it achieves
wide satisfaction and a maintained, long-term response (1, 2 and
3 years) after only one session.17,40,41
5 | CONCLUSIONS
Gynoid lipodystrophy is a frequent condition, whose psychological
impacts affect the quality of life of the patients who suffer it. It is
important to carry out regular revisions of the literature and analyze
the evidence published of several treatments for GLD because thus
far there are no randomized, controlled studies with proper-size
samples and adequate methodology. Likewise, it is necessary that
clinicians, who treat this type of patients, document and publish the
results of the treatments used because some of the current proce-
dures show promising results and it should be clearly established
what treatments have not shown efficacy to avoid the expense of
resources, time, and patients’ expectations.
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